酒石酸美托洛尔联合稳心颗粒治疗冠心病期前收缩的临床研究 |
| |
引用本文: | 田学峰.酒石酸美托洛尔联合稳心颗粒治疗冠心病期前收缩的临床研究[J].中国当代医药,2014,21(1):94-95. |
| |
作者姓名: | 田学峰 |
| |
作者单位: | 田学峰(黑龙江省医院,哈尔滨,150000); |
| |
摘 要: | 目的探讨酒石酸美托洛尔联合稳心颗粒治疗冠心病期前收缩的临床效果。方法选取本院2010年5月-2013年5月诊治的冠心病期前收缩患者93例,随机分为两组,对照组46例患者行酒石酸美托洛尔治疗,观察组47例患者行酒石酸美托洛尔联合稳心颗粒治疗,比较两组治疗效果及不良反应情况。结果观察组总有效率(97.9%)明显高于对照组(87.0%),差异有统计学意义(P〈0.05)。两组不良反应发生率比较,差异无统计学意义(P〉0.05)。结论酒石酸美托洛尔联合稳心颗粒治疗冠心病期前收缩效果显著,可明显改善患者的预后。
|
关 键 词: | 酒石酸美托洛尔 稳心颗粒 冠心痛期前收缩 |
Clinical research of metoprolol tartrate and wenxin granule in treatment of premature coronary heart disease |
| |
Authors: | TIAN Xue-feng |
| |
Institution: | TIAN Xue-feng (Heilongjiang Provincial Hospital, Harbin 150000,China) |
| |
Abstract: | Objective To investigate clinical effect of metoprolol tartrate and wenxin granule in treatment of premature coronary heart disease. Methods 93 patients with premature coronary heart disease in our hospital from May 2010 to May 2013 were selected, and randomly divided into two groups. 46 patients in control group were treated with metopro- lol tartrate,47 patients in observation group were treated with metoprolol tartrate and wenxin granule. Clinical effect and adverse reactions were compared between two groups. Results Total effective rate in observation group(97.9%) was sig- nificantly higher than control group (87.0%) ,the difference was significant (P〈0.05).The incidence of adverse reactions in two groups compared, difference was not statistically significant(P〉0.05). Conclusion Metoprolol tartrate and wenxin granule has significant effect in treatment of premature coronary heart disease, which can significantly improve progno- sis of patients. |
| |
Keywords: | Metoprolol tartrate Wenxin granule Premature coronary heart disease |
本文献已被 CNKI 维普 等数据库收录! |
|